These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 2114986)
1. Biliary lipids in familial combined hyperlipidaemia: effects of acipimox therapy. Ericsson S; Eriksson M; Angelin B Eur J Clin Invest; 1990 Jun; 20(3):261-5. PubMed ID: 2114986 [TBL] [Abstract][Full Text] [Related]
2. Metabolism of plasma low density lipoproteins in familial combined hyperlipidaemia: effect of acipimox therapy. Ericsson S; Eriksson M; Berglund L; Angelin B J Intern Med; 1992 Oct; 232(4):313-20. PubMed ID: 1402634 [TBL] [Abstract][Full Text] [Related]
3. Gemfibrozil in familial combined hyperlipidaemia: effect of added low-dose cholestyramine on plasma and biliary lipids. Odman B; Ericsson S; Lindmark M; Berglund L; Angelin B Eur J Clin Invest; 1991 Jun; 21(3):344-9. PubMed ID: 1909637 [TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic acid treatment in humans: effects on plasma and biliary lipid metabolism with special reference to very low density lipoprotein triglyceride and bile acid kinetics. Angelin B; Nilsell K; Einarsson K Eur J Clin Invest; 1986 Apr; 16(2):169-77. PubMed ID: 3089812 [TBL] [Abstract][Full Text] [Related]
5. Randomized crossover study of gemfibrozil versus lovastatin in familial combined hyperlipidemia: additive effects of combination treatment on lipid regulation. Zambón D; Ros E; Rodriguez-Villar C; Laguna JC; Vázquez M; Sanllehy C; Casals E; Sol JM; Hernández G Metabolism; 1999 Jan; 48(1):47-54. PubMed ID: 9920144 [TBL] [Abstract][Full Text] [Related]
6. Bezafibrate therapy and biliary lipids: effects of short-term and long-term treatment in patients with various forms of hyperlipoproteinaemia. Eriksson M; Angelin B Eur J Clin Invest; 1987 Oct; 17(5):396-401. PubMed ID: 3121342 [TBL] [Abstract][Full Text] [Related]
7. Effects of Acipimox on plasma lipids and biliary lipids in healthy subjects. Jung W; Kohlmeier M; Nikolaus T; Schlierf G Res Exp Med (Berl); 1985; 185(6):457-68. PubMed ID: 4089312 [TBL] [Abstract][Full Text] [Related]
9. Bile lipid secretion in obese and non-obese individuals with and without gallstones. Reuben A; Maton PN; Murphy GM; Dowling RH Clin Sci (Lond); 1985 Jul; 69(1):71-9. PubMed ID: 4064557 [TBL] [Abstract][Full Text] [Related]
10. Effect of the type of dietary fat on biliary lipid composition and bile lithogenicity in humans with cholesterol gallstone disease. Yago MD; González V; Serrano P; Calpena R; Martínez MA; Martínez-Victoria E; Mañas M Nutrition; 2005 Mar; 21(3):339-47. PubMed ID: 15797676 [TBL] [Abstract][Full Text] [Related]
11. Effects of fenofibrate on biliary lipids and bile acid pool size in patients with type IV hyperlipoproteinemia. Podda M; Zuin M Atherosclerosis; 1985 May; 55(2):135-42. PubMed ID: 4004987 [TBL] [Abstract][Full Text] [Related]
12. Modeling plasma lipoprotein-bile lipid relationships: differential impact of psyllium and cholestyramine in hamsters fed a lithogenic diet. Trautwein EA; Siddiqui A; Hayes KC Metabolism; 1993 Dec; 42(12):1531-40. PubMed ID: 8246766 [TBL] [Abstract][Full Text] [Related]
13. Parabolic relationship between plasma triacylglycerols and LDL-cholesterol in familial combined hyperlipidaemia: the multiple-type hyperlipidaemia explained? Brouwers MC; de Graaf J; van Greevenbroek MM; Georgieva AM; van der Kallen CJ; Ter Avest E; Stehouwer CD; Stalenhoef AF; de Bruin TW Clin Sci (Lond); 2008 Mar; 114(5):393-401. PubMed ID: 17953518 [TBL] [Abstract][Full Text] [Related]
15. Estrogen-induced gallstone formation in males. Relation to changes in serum and biliary lipids during hormonal treatment of prostatic carcinoma. Henriksson P; Einarsson K; Eriksson A; Kelter U; Angelin B J Clin Invest; 1989 Sep; 84(3):811-6. PubMed ID: 2760214 [TBL] [Abstract][Full Text] [Related]
16. Biliary lipid output during three meals and an overnight fast. I. Relationship to bile acid pool size and cholesterol saturation of bile in gallstone and control subjects. Northfield TC; Hofmann AF Gut; 1975 Jan; 16(1):1-11. PubMed ID: 806491 [TBL] [Abstract][Full Text] [Related]
17. Long-term effects of a sustained-release preparation of acipimox on dyslipidemia and glucose metabolism in non-insulin-dependent diabetes mellitus. Davoren PM; Kelly W; Gries FA; Hubinger A; Whately-Smith C; Alberti KG Metabolism; 1998 Mar; 47(3):250-6. PubMed ID: 9500558 [TBL] [Abstract][Full Text] [Related]
18. The effects of phenobarbital on biliary lipid metabolism in cholesterol gallstone subjects. Redinger RN Lipids; 1979 Mar; 14(3):277-84. PubMed ID: 449630 [TBL] [Abstract][Full Text] [Related]
19. The lipoprotein lipase (Asn291-->Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia. Hoffer MJ; Bredie SJ; Boomsma DI; Reymer PW; Kastelein JJ; de Knijff P; Demacker PN; Stalenhoef AF; Havekes LM; Frants RR Atherosclerosis; 1996 Jan; 119(2):159-67. PubMed ID: 8808493 [TBL] [Abstract][Full Text] [Related]
20. Clofibrate treatment and bile cholesterol saturation: short-term and long-term effects and influence of combination with chenodeoxycholic acid. Angelin B; Einarsson K; Leijd B Eur J Clin Invest; 1981 Jun; 11(3):185-9. PubMed ID: 6791937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]